FDA — authorised 8 November 2013
- Marketing authorisation holder: SUNOVION PHARMS INC
- Status: approved
🇺🇸 Aptiom in United States
FDA authorised Aptiom on 8 November 2013
Marketing authorisation
Aptiom in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Aptiom approved in United States?
Yes. FDA authorised it on 8 November 2013.
Who is the marketing authorisation holder for Aptiom in United States?
SUNOVION PHARMS INC holds the US marketing authorisation.